Nektar Reports Early Onset of Improvement with Rezpegaldesleukin in Atopic Dermatitis
Nektar Therapeutics says rezpegaldesleukin produced atopic dermatitis improvements as early as Week 2, accompanied by molecular changes the company links to the drug's mechanism.